Pharmacology and Pharmacokinetics of A Novel Nonpeptide Angiotensin II Receptor Antagonist

Pharmacology and Pharmacokinetics of A Novel Nonpeptide Angiotensin II Receptor Antagonist–DMP 811

Published:1995-01 Issue:8 Volume:17 Page:1233-1256
ISSN:1064-1963
Container-title:Clinical and Experimental Hypertension
language:en
Short-container-title:Clinical and Experimental Hypertension

Author:

Wong Pancras C.,Huang Shiew-Mei,Ardecky Robert J.,Carini David J.,Chiu Andrew T.,Price William A.,Agra Allison M.,Wexler Ruth R.,Pieter M. M.,Timmermans W. M.

Publisher

Informa UK Limited

Subject

General Medicine,Physiology,Internal Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/10641969509037406

Reference25 articles.

1. The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist

2. Losartan (DuP 753), An Orally Active Nonpeptide Angiotensin II Receptor Antagonist

3. Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist

4. Pharmacokinetics and biochemical efficacy after single and multiple oral administration of losartan, an orally active nonpeptide angiotensin II receptor antagonist, in humans.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologically active metabolites in drug discovery;Bioorganic & Medicinal Chemistry Letters;2021-09

2. Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists—A perspective;Bioorganic & Medicinal Chemistry;2010-12

3. Nonpeptide Angiotensin II Receptor Antagonists: The Next Generation in Antihypertensive Therapy;Journal of Medicinal Chemistry;1996-01-01

4. Effects of structural modifications on the intestinal permeability of angiotensin II receptor antagonists and the correlation of in vitro, in situ, and in vivo absorption;Pharmaceutical Research;1996